Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab

Published:2020-03-13 Issue:8 Volume:55 Page:1580-1587
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bacigalupo Andrea,Angelucci Emanuele,Raiola Anna Maria,Varaldo Riccardo,Di Grazia Carmen,Gualandi Francesca,Benedetti Edoardo,Risitano Antonio,Musso Maurizio,Zallio Francesco,Ciceri Fabio,Chiusolo Patrizia^ORCID,Sica Simona,Rambaldi Alessandro^ORCID,Bonifazi Francesca,Parma Matteo,Martino Massimo^ORCID,Onida Francesco,Iori Anna Paola,Selleri Carmine,Borghero Carlo,Bertaina Alice,Prezioso Lucia,Algeri Mattia,Locatelli Franco

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0855-z.pdf

Reference21 articles.

1. Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood. 2011;117:3214–9.

2. Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transpl. 2012;18:1150–63.

3. Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, et al. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transpl. 2014;49:168–73.

4. Mielcarek M, Storer BE, Boeckh M, Green ML, McDonald GB, Carpenter PA, et al. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood. 2009;113:2888–94.

5. Van Lint MT, Milone G, Leotta S, Uderzo C, Scimè R, Dallorso S, et al. Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. Blood. 2006;107:4177–81.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD;Cells;2024-09-11

2. Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program;Bone Marrow Transplantation;2024-02-15

3. Acute graft versus host disease 1976–2020: reduced incidence and predictive factors;Frontiers in Medicine;2024-01-24

4. Extracellular Vesicles: Biology and Their Use as Potential Biomarkers in Hematopoietic Post-Transplant Complications;Comprehensive Hematology and Stem Cell Research;2024

5. Novel Pharmacological Treatment Options of Steroid-Refractory Graft-versus-Host Disease;Advances in Hematology;2023-12-06